» Articles » PMID: 33651292

Correlation Between Polio Immunization Coverage and Overall Morbidity and Mortality for COVID-19: an Epidemiological Study

Abstract

We conducted the current analysis to determine the potential role of polio vaccination in the context of the spread of COVID-19. Data were extracted from the World Health Organization's (WHO) Global Health Observatory data repository regarding the polio immunization coverage estimates and correlated to the overall morbidity and mortality for COVID-19 among different countries. Data were analyzed using R software version 4.0.2. Mean and standard deviation were used to represent continuous variables while we used frequencies and percentages to represent categorical variables. The Kruskal-Wallis H test was used for continuous variables since they were not normally distributed. Moreover, the Spearman rank correlation coefficient (rho) was used to determine the relationship between different variables. There was a significantly positive correlation between the vaccine coverage (%) and both of total cases per one million populations (rho = 0.37; p-value < 0.001) and deaths per one million populations (rho = 0.30; p-value < 0.001). Moreover, there was a significant correlation between different income groups and each of vaccine coverage (%) (rho = 0.71; p-value < 0.001), total cases per one million populations (rho = 0.50; p-value < 0.001), and deaths per one million populations (rho = 0.39; p-value < 0.001). All claims regarding the possible protective effect of Polio vaccination do not have any support when analyzing the related data. Polio vaccination efforts should be limited to eradicate the disease from endemic countries; however, there is no evidence to support the immunization with live-attenuated vaccines for the protection against COVID-19.

Citing Articles

Effect of restricted emissions during COVID-19 on atmospheric aerosol chemistry in a Greater Cairo suburb: Characterization and enhancement of secondary inorganic aerosol production.

Hassan S, Alghamdi M, Khoder M Atmos Pollut Res. 2022; 13(11):101587.

PMID: 36340245 PMC: 9627639. DOI: 10.1016/j.apr.2022.101587.


Use of oral polio vaccine and the incidence of COVID-19 in the world.

Habibzadeh F, Chumakov K, Sajadi M, Yadollahie M, Stafford K, Simi A PLoS One. 2022; 17(3):e0265562.

PMID: 35298546 PMC: 8929581. DOI: 10.1371/journal.pone.0265562.


Limited Secondary Transmission of the Novel Coronavirus (SARS-CoV-2) by Asymptomatic and Mild COVID-19 Patients in Bhutan.

Tshokey T, Choden J, Dorjee K, Pempa P, Yangzom P, Gyeltshen W Am J Trop Med Hyg. 2020; 104(2):490-495.

PMID: 33308385 PMC: 7866324. DOI: 10.4269/ajtmh.20-0672.

References
1.
Mshelia S, Blackmore C, Archer R, Booth A . Factors affecting the successful implementation of Global Polio Eradication Initiative (GPEI) in low- and middle-income countries. J Glob Health. 2020; 10(1):010322. PMC: 7125945. DOI: 10.7189/jogh.10.010322. View

2.
Jensen K, Benn C, van Crevel R . Unravelling the nature of non-specific effects of vaccines-A challenge for innate immunologists. Semin Immunol. 2016; 28(4):377-83. DOI: 10.1016/j.smim.2016.05.005. View

3.
Li K, Wohlford-Lenane C, Perlman S, Zhao J, Jewell A, Reznikov L . Middle East Respiratory Syndrome Coronavirus Causes Multiple Organ Damage and Lethal Disease in Mice Transgenic for Human Dipeptidyl Peptidase 4. J Infect Dis. 2015; 213(5):712-22. PMC: 4747621. DOI: 10.1093/infdis/jiv499. View

4.
Harrison K, Rahimi N, Danovaro-Holliday M . Factors limiting data quality in the expanded programme on immunization in low and middle-income countries: A scoping review. Vaccine. 2020; 38(30):4652-4663. DOI: 10.1016/j.vaccine.2020.02.091. View

5.
de Winter J, Gosling S, Potter J . Comparing the Pearson and Spearman correlation coefficients across distributions and sample sizes: A tutorial using simulations and empirical data. Psychol Methods. 2016; 21(3):273-90. DOI: 10.1037/met0000079. View